Following several consecutive announcements of vaccine candidate success in November 2020, markets began pricing in an end to the COVID-19 pandemic. Shortly after these vaccines were deemed effective, many were fast-tracked for approval by governments around the world, and vaccination programs began in earnest in December of last year. Now, in the second month of 2021, many investors may be wondering: how is the vaccine rollout progressing, and how close is the pandemic to being over?